Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Humalog® Mix50/50TM administered as 3 injections daily is equivalent to Humalog® plus Humulin
N® insulin administered as 6 separate injections daily in terms of glucose control, but may
have some advantages due to increased ease of use.
Phase:
Phase 4
Details
Lead Sponsor:
Sansum Diabetes Research Institute William Sansum Diabetes Center